152 related articles for article (PubMed ID: 7586731)
1. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus.
Combates NJ; Degiannis D; Raskova J; Raska K
Clin Immunol Immunopathol; 1995 Dec; 77(3):221-8. PubMed ID: 7586731
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
[No Abstract] [Full Text] [Related]
3. In vitro expression of activation markers and lymphocyte proliferation in response to interleukin 12: effect of immunosuppressive agents.
Degiannis D; Koniavitou K
Transplant Proc; 1996 Dec; 28(6):3062-4. PubMed ID: 8962187
[No Abstract] [Full Text] [Related]
4. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
[TBL] [Abstract][Full Text] [Related]
5. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine.
Kimball PM; Kerman RH; Kahan BD
Transplantation; 1991 Feb; 51(2):486-90. PubMed ID: 1825247
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2.
Rebollo A; Mérida I; Gómez J; Pitton C; Silva A; Martínez C; García A
Cytokine; 1995 Apr; 7(3):277-86. PubMed ID: 7543780
[TBL] [Abstract][Full Text] [Related]
7. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
[TBL] [Abstract][Full Text] [Related]
8. Responsiveness of preactivated B cells to IL-2 and IL-6. Effect of cyclosporine and rapamycin.
Hornung N; Raskova J; Raska K; Degiannis D
Transplantation; 1993 Oct; 56(4):985-90. PubMed ID: 7692641
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of re-expression of surface CD4, but not CD8, on activated human T-lymphocytes by the immunosuppressive drugs dexamethasone and cyclosporine A: correlation with inhibition of proliferation.
Haczku AF; Kay AB; Corrigan CJ
Int J Immunopharmacol; 1996 Jan; 18(1):45-51. PubMed ID: 8732432
[TBL] [Abstract][Full Text] [Related]
11. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-15 is the main mediator of lymphocyte proliferation in cultures mixed with human kidney tubular epithelial cells.
Lewis E; Weiler M; Chaimovitz C; Douvdevani A
Transplantation; 2001 Sep; 72(5):886-90. PubMed ID: 11571455
[TBL] [Abstract][Full Text] [Related]
13. Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays.
Ferron GM; Pyszczynski NA; Jusko WJ
Transplantation; 1998 May; 65(9):1203-9. PubMed ID: 9603169
[TBL] [Abstract][Full Text] [Related]
14. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of anti-CD3 antibody-induced mouse T cell activation by pentoxifylline in combination with rapamycin or A77 1726 (leflunomide).
Richard M; Hoskin DW
Int J Immunopharmacol; 1998; 20(4-5):241-52. PubMed ID: 9730259
[TBL] [Abstract][Full Text] [Related]
16. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination.
Kahan BD; Tejpal N; Gibbons-Stubbers S; Tu Y; Wang M; Stepkowski S; Chou TC
Transplantation; 1993 Apr; 55(4):894-900. PubMed ID: 8475566
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells.
Kim HS; Raskova J; Degiannis D; Raska K
Clin Exp Immunol; 1994 Jun; 96(3):508-12. PubMed ID: 8004821
[TBL] [Abstract][Full Text] [Related]
18. [The effect of mycophenolic acid on activation antigen expression and in vitro T lymphocytes proliferation in peripheral blood].
Zheng W; Huang H; Xu C
Zhonghua Nei Ke Za Zhi; 2002 May; 41(5):329-32. PubMed ID: 12133428
[TBL] [Abstract][Full Text] [Related]
19. The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes.
McCarthy SA; Cacchione RN; Mainwaring MS; Cairns JS
Transplantation; 1992 Sep; 54(3):543-7. PubMed ID: 1384186
[TBL] [Abstract][Full Text] [Related]
20. Human fetal retinal pigment epithelium suppresses the activation of CD4(+) and CD8(+) T-cells.
Farrokh-Siar L; Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Graefes Arch Clin Exp Ophthalmol; 1999 Nov; 237(11):934-9. PubMed ID: 10541905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
